Contact
Please use this form to send email to PR contact of this press release:
Harpoon Therapeutics Provides an Update on the HPN217 Development and Option Agreement with AbbVie
TO:
Please use this form to send email to PR contact of this press release:
Harpoon Therapeutics Provides an Update on the HPN217 Development and Option Agreement with AbbVie
TO: